There was no difference in mortality rates between NB-HR and other ST patients (OR 1.12, 95% CI [0.1, 12.5]), however, NB-HR during induction chemotherapy had a lower mortality rate than both AML patients (OR 3.08, 95% CI [0.31, 30.2]) and SCT recipients (OR 4.44, 95% CI [0.55, 36.12]), although these findings did not reach statistical significance.
← all excerpts
High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy.
1
—
—